AlloRx
Asset
Cultured allogeneic adult umbilical cord derived mesenchymal stem cells infused intravenously to improve frailty.
- Stage
- Phase 1
- Modality
- Cell therapy
- Target
- Inflammation
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Frailty
Phase 1, Recruiting, NCT05018767, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors2
- Aging relevance3
Every asset’s record: target, stage, trials and the evidence behind it.